Radiotherapy

	Reporting Data Item	Business Justification	Definition Note: Where ‘NHS Wales Data Dictionary’ the definition is as per the Data Dictionary.	Permissible Values
9. RADIOTHERAPY
9.0 ENCDv4.5b (10.8) DAHNO	Date treatment started (radiotherapy)	To determine the time interval between referral and diagnosis by the specialist team and the start of treatment. Required to be able to the measure survival time from the start of treatment. To enable the date of first definitive treatment to be recorded.	The date on which the radiotherapy first administered.
9.1 ENCDv4.5b (10.6) DAHNO	Treatment intent (radiotherapy)	To assess patterns of radiotherapy practice for comparisons with best practice guidelines.	The intended outcome of the radiotherapy to be administered.	Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review. • Adjuvant • Neoadjuvant • Radical (curative) • Palliative
9.2 DAHNO	Radiotherapy type	This data item is required to distinguish which type of radiotherapy is administered to a patient.	The type of radiotherapy administered.	Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review. • Teletherapy • Brachytherapy
9.3 DAHNO	Anatomical treatment site (radiotherapy)	To enable analysis of radiotherapy treatment sites. Required for submission to the national clinical head & neck cancer audit.	The part(s) of the body to which the prescription was administered.	Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review.